TechCrunch: M&A

JULY 31, 2023

Publicly traded Dynatrace already offers a comprehensive suite of observability tools, but the addition of Rookout will allow it to expand these services with code-level observability into production environments. Rookout CEO Shahar Fogel and CTO Liran Haimovitch.

Engineering 231

Engineering Public Trading Collaboration IT 231

OfficeHours

AUGUST 9, 2023

Private equity involves investing capital directly into private businesses that are not publicly traded on stock exchanges (that would be a hedge fund). Collaborative skills are crucial for effective teamwork and achieving common objectives, and given the long hours, “fit” is important as well.

Private Equity 130

Private Equity Equities Investment Banking Investment 130

OfficeHours

AUGUST 20, 2023

Private equity involves investing capital directly into private businesses that are not publicly traded on stock exchanges (that would be a hedge fund). Limited partner private equity shops are generally firms that raise capital (funds) and deploy that capital in various investments headed by a GP.

Private Equity 130

Private Equity Equities Investment Banking Finance 130

Focus Investment Banking

FEBRUARY 25, 2024

I still recall the metric that was drilled into me back then: hit $50 million in revenue and a few back-to-back years of profitability and you, too, can go public. The benefits of going public are significant. Lastly, going public is a liquidity event for the founders and early investors, allowing them to cash in on their success.

Private Equity 52

Private Equity IPO Equities Public Trading 52

Software Equity Group

FEBRUARY 28, 2023

Stock prices and valuations of many leading public SaaS companies have fallen drastically from the beginning of 2022—but while that will affect the private market, it does not necessarily spell doom and gloom. This post will examine the current state of public SaaS company valuations and what it means for private companies.

Valuation 52

Valuation M&A Stock Profitability 52

Cooley M&A

JANUARY 25, 2023

Will 2023 see a resurgence of traditional public M&A deals or will macro factors and the looming threat of regulatory review continue to push biotechnology companies down creative paths? It’s a more challenging market environment right now than we’ve seen in many years,” said Charlie Kim , who co-chairs Cooley’s capital markets practice.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 22, 2020

And, in general, we saw large pharmaceutical companies deploy substantial amounts of capital in 2019 to acquire innovative biotech companies that are advancing the development of novel therapies for oncology, orphan diseases and other unmet medical needs. Year of the Life Sciences Mega-Deals. billion; and Synthorx’s sale to Sanofi $2.5

M&A 40

M&A Pharmaceutical Acquisitions Capital 40